MFCD00167693
- Product Name
- MFCD00167693
- CAS No.
- 199735-88-1
- Chemical Name
- MFCD00167693
- Synonyms
- HY-107999;MFCD00167693;CADD522 ,S0790;CADD522, 10 mM in DMSO;3-(N-(3,4-DICHLOROPHENYL)CARBAMOYL)-5-NORBORNENE-2-CARBOXYLIC ACID;3-[(3,4-dichlorophenyl)carbamoyl]bicyclo[2.2.1]hept-5-ene-2-carboxylic acid;3-{[(3,4-dichlorophenyl)amino]carbonyl}bicyclo[2.2.1]hept-5-ene-2-carboxylic acid;Bicyclo[2.2.1]hept-5-ene-2-carboxylic acid, 3-[[(3,4-dichlorophenyl)amino]carbonyl]-;inhibit,MDA-231,Inhibitor,Reactive Oxygen Species,CADD 522,MCF7,MDA-468,breast cancer,CADD522,T47D-RUNX2,CADD-522
- CBNumber
- CB63058321
- Molecular Formula
- C15H13Cl2NO3
- Formula Weight
- 326.17
- MOL File
- 199735-88-1.mol
MFCD00167693 Property
- Boiling point:
- 569.1±50.0 °C(Predicted)
- Density
- 1.529±0.06 g/cm3(Predicted)
- storage temp.
- 2-8°C
- solubility
- DMSO:157.5(Max Conc. mg/mL);482.87(Max Conc. mM)
Ethanol:65.0(Max Conc. mg/mL);199.28(Max Conc. mM) - form
- A solid
- pka
- 4.19±0.40(Predicted)
- color
- White to off-white
- InChI
- 1S/C15H13Cl2NO3/c16-10-4-3-9(6-11(10)17)18-14(19)12-7-1-2-8(5-7)13(12)15(20)21/h1-4,6-8,12-13H,5H2,(H,18,19)(H,20,21)
- InChIKey
- YSDNWNOGHQYWPK-UHFFFAOYSA-N
- SMILES
- O=C(C1C2C=CC(C1C(NC3=CC=C(C(Cl)=C3)Cl)=O)C2)O
Safety
- WGK Germany
- WGK 3
- Storage Class
- 11 - Combustible Solids
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Warning
- Hazard statements
-
H302Harmful if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
- Precautionary statements
-
P261Avoid breathing dust/fume/gas/mist/vapours/spray.
P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
N-Bromosuccinimide Price
- Product number
- S720224
- Product name
- 3-(N-(3,4-DICHLOROPHENYL)CARBAMOYL)-5-NORBORNENE-2-CARBOXYLIC ACID
- Purity
- AldrichCPR
- Packaging
- 50MG
- Price
- $113
- Updated
- 2025/07/31
- Product number
- 159610
- Product name
- 3-{[(3,4-Dichlorophenyl)amino]carbonyl}bicyclo[2.2.1]hept-5-ene-2-carboxylic acid
- Packaging
- 0.500g
- Price
- $120
- Updated
- 2021/12/16
- Product number
- FD136060
- Product name
- 3-{[(3,4-Dichlorophenyl)amino]carbonyl}bicyclo[2.2.1]hept-5-ene-2-carboxylic acid
- Packaging
- 1g
- Price
- $128
- Updated
- 2021/12/16
- Product number
- FD136060
- Product name
- 3-{[(3,4-Dichlorophenyl)amino]carbonyl}bicyclo[2.2.1]hept-5-ene-2-carboxylic acid
- Packaging
- 500mg
- Price
- $75
- Updated
- 2021/12/16
- Product number
- 159610
- Product name
- 3-{[(3,4-Dichlorophenyl)amino]carbonyl}bicyclo[2.2.1]hept-5-ene-2-carboxylic acid
- Packaging
- 1g
- Price
- $150
- Updated
- 2021/12/16
MFCD00167693 Chemical Properties,Usage,Production
Uses
CADD522 is a potent inhibitor of RUNX2(runt-related transcription factor-2)-DNA.
Biological Activity
CADD522 is a cell-permeable, bioavailable, non-toxic carbamoyl-bicycloheptene-carboxylate th at inhibits RUNX2-DNA binding, thereby increases RUNX2 stability, upregulates RUNX2 expression levels and downregulates RUNX2 responsive genes transcription. CADD522 inhibits mitochondrial oxidative phosphorylation by decreasing the mitochondrial oxygen consumption rate and ATP production in human breast cancer cells in a RUNX2-independent manner. CADD-522 suppresses in vivo tumor growth and metastasis, and appreciably prolongs the survival rates without the need for surgery or chemotherapy.
in vivo
CADD522 (1, 5 and 20 mg/kg; i.p.; twice a week for 45 days) delays the onset of the tumors and suppresses tumor growth in mice[1].
CADD522 (10 mg/kg; i.p.; twice a week for 11 days) suppresses tumor metastasis and inhibits expression of Ki-67 in mice[1].
| Animal Model: | Female mice (6-week-old; MMTV-PyMT transgenic model)[1]. |
| Dosage: | 1, 5 and 20 mg/kg |
| Administration: | Intraperitoneal injection; twice a week for 45 days. |
| Result: | Delayed the onset of the tumors, delayed tumor development and reduced tumor burden in transgenic MMTV-PyMT mice. Reduced the tumor weight in mice. |
| Animal Model: | Female NOD scid gamma (NSG) mice and nude mice (TNBC-PDX Br-001 model)[1]. |
| Dosage: | 10 mg/kg |
| Administration: | Intraperitoneal injection; twice a week for 11 days. |
| Result: | Significant decreased tumor volume and markedly inhibited expression of Ki-67. Inhibited experimental metastasis of BC cells in vivo.(did not significantly decrease body weight or influence the general health of animals). |
IC 50
RUNX2: 10 nM ()
MFCD00167693 Preparation Products And Raw materials
Raw materials
Preparation Products
MFCD00167693 Suppliers
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
- Country
- United States
- ProdList
- 12952
- Advantage
- 65
- Tel
- 021-65675885 18964387627
- Fax
- 021-65675885
- info@efebio.com
- Country
- China
- ProdList
- 9803
- Advantage
- 58
- Tel
- 021-61312847; 18021002903
- Fax
- QQ:3008007432
- 3008007409@qq.com
- Country
- China
- ProdList
- 71826
- Advantage
- 60
- Tel
- 15076683720
- Fax
- 022-23754520
- klq@cw-bio.com
- Country
- China
- ProdList
- 9431
- Advantage
- 55
- Tel
- 177-54423994 17754423994
- Fax
- QQ:2853530913
- 2853530910@QQ.com
- Country
- China
- ProdList
- 8000
- Advantage
- 62
- Tel
- 021-31433387 15618786686
- Fax
- QQ:1369748377
- sales@rechemscience.com
- Country
- China
- ProdList
- 2961
- Advantage
- 58
- Tel
- 010-50973130 18101056239
- 3193328036@qq.com
- Country
- China
- ProdList
- 29662
- Advantage
- 68
- Tel
- 13761635123
- Fax
- 1014988033@qq
- sales@linyuepharm.com
- Country
- China
- ProdList
- 5229
- Advantage
- 55
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
- Country
- United States
- ProdList
- 32470
- Advantage
- 58
- Tel
- +1-708-310-1919 +1-13798911105
- Fax
- 708-557-7486
- sales@invivochem.cn
- Country
- United States
- ProdList
- 6391
- Advantage
- 58